drugset / Trial / NCT00312871

Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency

NCT00312871

Phase 4 Terminated 217 enrolled Janssen Cilag S.A.S.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to assess the effect of an early and complete correction of anemia after treatment with epoetin alfa on the rate of progression of chronic renal failure (which involves improper functioning of the kidneys). It also assesses the effect of hemoglobin normalization (correction of anemia) on the need for renal (kidney) replacement therapy, quality of life, blood pressure control, hospital admissions, mortality, cardiovascular events, nutritional status and safety.

Timeline

Start
2001-02
Primary completion
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic 25 iu/kg Subcutaneous
Subject epoetin alfa Protein / enzyme biologic 100 iu/kg Subcutaneous